Wolfe Research initiated coverage on SailPoint with an Outperform rating and a $27 price target, arguing the identity governance specialist is positioned to deliver sustained high-growth as it shifts ...
The Cigna Group (NYSE:CI) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts. On October 15, Wolfe Research ...
Exxon Mobil maintains its position as Wolfe Research’s top major idea in the oil and gas sector. The company is poised for a ...
Fintel on MSN
Wolfe Research Initiates Coverage of Sila Realty Trust (SILA) with Outperform Recommendation
Fintel reports that on October 20, 2025, Wolfe Research initiated coverage of Sila Realty Trust (NYSE:SILA) with a Outperform ...
Wolfe Research has upgraded Advanced Micro Devices stock to Outperform from Peer Perform and set a $300 price target, a move driven by the expected financial boost from the chipmaker’s new deal with ...
C3.ai, Inc. (NYSE:AI) is one of the AI Stocks Analysts Are Watching Closely. On August 11, Wolfe Research analyst Gal Munda reiterated an Underperform rating on the stock with a $15.00 price target.
Investing.com - A series of risks could spark a downturn in a stock market currently marked by elevated valuations and ...
Wolfe Research downgraded shares of PayPal Holdings (NASDAQ:PYPL) to Peer Perform from Outperform, citing concerns that momentum in the company’s branded checkout business may take longer to ...
Otis trades at about 21 times forward earnings, below its peers at 26–29 times, and Wolfe said that discount could narrow as growth improves. The firm called the company’s field-quality and retention ...
In the competitive landscape of US internet stocks, Wolfe Research has identified several standout performers worth investor attention. These companies demonstrate strong fundamentals, innovative ...
Investing.com - There are now 50-50 odds that a prolonged U.S. government shutdown will stretch out through the end of October, according to Wolfe Research. The shuttering of the federal government ...
Shares of Sphere Entertainment (SPHR) are up for a second day after the company announced Monday that ticket sales for The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results